Lv1
10 积分 2023-10-24 加入
[Expert consensus on combination therapies of oral anti-diabetic drugs for adults with type 2 diabetes (2025 edition)]
2个月前
已完结
Cadonilimab with chemotherapy in HER2-negative gastric or gastroesophageal junction adenocarcinoma: the phase 1b/2 COMPASSION-04 trial
2个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
2个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
2个月前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
2个月前
已完结
Bispecific antibodies: a mechanistic review of the pipeline
2个月前
已完结
Bisulfite-free direct detection of 5-methylcytosine and 5-hydroxymethylcytosine at base resolution
3个月前
已完结
3D bioprinted cancer models: from basic biology to drug development
4个月前
已完结
Patient‐Derived 3D‐Bioprinted Intrahepatic Cholangiocarcinoma Models Recapitulate Tumor Autologous Traits and Predict Personalized Adjuvant Therapy
4个月前
已完结
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety
5个月前
已完结
皖公网安备34019202002308
